Evidence map›Paper›PMID 28904673›Full record

ArticleThe Pan African medical journal2017

Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods.

Faustinos Tatenda Takawira, Racheal Shamiso Dube Mandishora, Zephaniah Dhlamini, Ellen Munemo, Babill Stray-Pedersen

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Drug Resistance and Molecular Characteristics ofJournal of personalized medicine · 2022
    Article
  8. Article
  9. Frequency of rpoB, katG, and inhA Gene Polymorphisms Associated with Multidrug-ResistantInterdisciplinary perspectives on infectious diseases · 2022
    Article
  10. Frontiers in veterinary science · 2021
    Article
  11. Mutations inInternational journal of microbiology · 2020
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Faustinos Tatenda TakawiraDepartment of Applied Biology and Biochemistry, National University of Science and Technology (NUST), Bulawayo, Zimbabwe.
Racheal Shamiso Dube MandishoraDepartment of Microbiology, College of Health Sciences, University of Zimbabwe, Mazowe Street, Parirenyatwa Complex, Avondale, Harare, Zimbabwe.
Zephaniah DhlaminiDepartment of Applied Biology and Biochemistry, National University of Science and Technology (NUST), Bulawayo, Zimbabwe.
Ellen MunemoNational Microbiology Reference Laboratory, Harare Central Hospital, Southerton, Harare, Zimbabwe.
Babill Stray-PedersenDivision of Woman, Oslo University Hospital, Rikshospitalet and Institute of Clinical Medicine, University in Oslo, Norway.
National University of Science and Technology · ZWHarare Central Hospital · ZWOslo University Hospital · NOUniversity of Zimbabwe · ZW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTuberculosis remains the leading causes of death worldwide with frequencies of mutations in rifampicin and isoniazid resistant Mycobacterium tuberculosis isolates varying according to geographical location. There is limited information in Zimbabwe on specific antibiotic resistance gene mutation patterns in MTB and hence, increased rate of discordant results and mortality due to inappropriate antibiotic prescriptions. The rpoB and katG genes molecular markers are used for detecting rifampicin and isoniazid resistance respectively. Some mutations within these gene sequences are associated with drug resistance as they directly alter gene function. The objectives of this research was to determine the drug resistance profiles in M. tuberculosis isolates that are phenotypically resistant but not detected by the GeneXpert and MTBDRplus kit and also to detect mutations in the rpoB and katG genes which are not detected by the Hain Genotype MTBDRplus kit and GeneXpert diagnosis.

methodsPCR was used for the amplification of the rpoB and katG genes from MTB isolates collected from human clinical samples between 2008 and 2015. The genes were sequenced and compared to the wild type MTB H37Rv rpoB (accession number L27989) and kat G genes (KP46920), respectively. Sequence analysis results were compared to genotyping results obtained from molecular assays and culture results of all isolates.

resultsThe most frequent mutation responsible for rifampicin resistance was (25/92) S531L that was detected by using all molecular assays. Some inconsistencies were observed between phenotypic and genotypic assay results for both katG and rpoB genes in 30 strains. For these, eight codons; G507S, T508A, L511V, del513-526, P520P, L524L, R528H, R529Q and S531F were novel mutations. In addition, the I572P/F, E562Q, P564S, and Q490Y mutations were identified as novel mutations outside the rifampicin resistance determining region. In katG gene, amino acid changes to threonine, asparagine and isoleucine exhibited high degrees of polymorphism such as V473N, D311N, and L427I. The R463L (20/92) amino acid substitution was most common but was not associated with isoniazid resistance.

conclusionThese finding indicate that molecular assay kit diagnosis that is based on the rpoB and katG genes should be improved to cater for the genetic variations associated with the geographic specificity of the target genes and be able to detect most prevalent mutations in different areas.

Indexed as

AdolescentAdultAgedAmino Acid SubstitutionAntitubercular AgentsBacterial ProteinsCatalaseChildDNA-Directed RNA PolymerasesDrug Resistance, Multiple, BacterialFemaleGenotypeHumansIsoniazidMaleMiddle AgedAntitubercular AgentsBacterial ProteinsCatalaseDNA-Directed RNA PolymerasesIsoniazidkatG protein, Mycobacterium tuberculosisRifampinrpoB protein, Mycobacterium tuberculosisDNA and PCRGeneXperthains genotype MTBDRpluskatGMutationmycobacterium tuberculosisrpoBsequencing

Identifiers

PMID28904673
PMCPMC5567934
OpenAlexW2729935006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.